Skip to content

An International Multicenter Prospective Observational Study to Evaluate the Epidemiology, Humanistic and Economic Outcomes of Treatment for Chronic Hepatitis C Virus (HCV)

An International Multicenter Prospective Observational Study to Evaluate the Epidemiology, Humanisti

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005312
Enrollment
Unknown
Registered
2014-09-24
Start date
2014-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis C Virus

Interventions

Sponsors

People's Hospital, Beijing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed of having a chronic HCV infection; 2. Male or female and 18 years of age or older; 3. Speaks the language of the provided patient questionnaires; 4. Signed a patient authorization form to use and disclose personal health information (or informed consent, where applicable).

Exclusion criteria

Exclusion criteria: 1. Diagnosed of having an acute HCV infection; 2. Currently on treatment for HCV; 3. Participates in a concurrent interventional clinical trial (phase 1, 2 or 3 or a Compassionate Use or Early Access Program).

Design outcomes

Primary

MeasureTime frame
Description of the general epidemiology of patient;Proportion of patients planned for IFN containing ;Changes in HRQoL (EQ-5D-5L and HCV-PRO) over the t;Treatment completion status:a) Includes determinin;Percentages of presenteeism, absenteeism, total wo;Degree of resource utilization associated with HCV;

Countries

China

Contacts

Public ContactChunyan Yuan
chunyan.yuan@abbvie.com+86 21-62631361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026